Update: therapie der necrobiosis lipoidica

M Peckruhn, J Tittelbach… - JDDG: Journal der …, 2017 - Wiley Online Library
Die Necrobiosis lipoidica ist eine seltene granulomatöse Erkrankung von bisher
unzureichend geklärter Ätiologie. Häufig stellt die bei Diabetikern gehäuft zu beobachtende …

[HTML][HTML] ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes

FH Mahmud, NS Elbarbary, E Fröhlich-Reiterer… - Pediatric …, 2018 - ncbi.nlm.nih.gov
• Screening of thyroid function by measurement of thyroid stimulating hormone (TSH) and
antithyroid peroxidase antibodies is recommended at the diagnosis of diabetes (A) and …

[PDF][PDF] ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes.

E Fröhlich‐Reiterer, NS Elbarbary, K Simmons… - Pediatric …, 2022 - endoped.ro
ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated
conditions in children and adolescents wit Page 1 ISPAD GUIDELINES ISPAD Clinical Practice …

Skin involvement in paediatric patients with type 1 diabetes

S Passanisi, G Salzano… - Current Diabetes …, 2022 - ingentaconnect.com
Skin involvement is an overlooked aspect in the management of paediatric patients with type
1 diabetes. A comprehensive search of published literature using the PubMed database was …

Cutaneous Manifestations Associated with Diabetes Mellitus—A Retrospective Study

D Vâță, DE Stanciu, D Temelie-Olinici… - Diseases, 2023 - mdpi.com
Diabetes mellitus (DM) is one of the world's most important health problems, affecting more
than half a billion of the world's population today, with an ever-increasing prevalence …

Necrobiosis lipoidica in childhood: a review of literature with emphasis on therapy

A Schiefer‐Niederkorn, B Sadoghi… - JDDG: Journal der …, 2023 - Wiley Online Library
Necrobiosis lipoidica (NL) is a rare chronic granulomatous disease that manifests as sharply
demarcated, telangiectatic, brownish‐red plaques with atrophic yellowish centers prone to …

A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation

M Naumowicz, S Modzelewski, A Macko… - International Journal of …, 2024 - mdpi.com
Necrobiosis lipoidica (NL) is a rare granulomatous disease of a not fully understood
etiopathogenesis. Classically, NL is associated with insulin-dependent diabetes mellitus …

Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile.

G Ganzetti, A Campanati, E Molinelli… - Current Drug Safety, 2016 - europepmc.org
Biologic treatments have modified the therapeutic armamentarium in the treatment of many
dermatological and non-dermatological diseases and data on literature have widely focused …

Literaturrecherche zur Therapie der Necrobiosis lipoidica in der Kindheit

A Schiefer‐Niederkorn, B Sadoghi… - JDDG: Journal der …, 2023 - Wiley Online Library
Die Necrobiosis lipoidica (NL) ist eine seltene granulomatöse Erkrankung mit scharf
begrenzten, teleangiektatischen, braun‐roten Plaques mit atroph‐gelblichen Zentren, die zu …

Concomitant granuloma annulare and necrobiosis lipoidica: do they have a related pathogenesis?

JN Harb, EV George, A Walker… - Clinical & Experimental …, 2019 - search.ebscohost.com
Granuloma annulare (GA) and necrobiosis lipoidica (NL) are cutaneous granulomatous
diseases of unclear aetiology. They differ in lesional morphology, distribution, clinical course …